tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rossari Biotech Publishes Extract of Q3 FY26 Consolidated Unaudited Results in Newspapers

Story Highlights
  • Rossari Biotech has published newspaper extracts of its consolidated unaudited results.
  • The disclosure fulfills SEBI listing norms and widens access to Rossari’s recent financial performance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Rossari Biotech Publishes Extract of Q3 FY26 Consolidated Unaudited Results in Newspapers

Claim 50% Off TipRanks Premium

Rossari Biotech Ltd ( (IN:ROSSARI) ) has issued an announcement.

Rossari Biotech Ltd has notified the stock exchanges that it has published in Financial Express and Loksatta an extract of its consolidated unaudited financial results for the quarter and nine months ended 31 December 2025, in compliance with disclosure requirements under SEBI’s Listing Regulations. The move is a routine regulatory step aimed at ensuring wider public dissemination of its latest financial performance to investors and other stakeholders, reinforcing transparency and adherence to listing norms, though the detailed financial figures themselves are available only in the full results published separately.

More about Rossari Biotech Ltd

Rossari Biotech Ltd is an India-listed company in the specialty chemicals sector, offering a range of textile, home, personal care and other performance chemicals, with its shares traded on BSE and the National Stock Exchange of India under the code ROSSARI.

Average Trading Volume: 1,562

Technical Sentiment Signal: Sell

Current Market Cap: 29.61B INR

For detailed information about ROSSARI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1